<DOC>
	<DOC>NCT00913458</DOC>
	<brief_summary>Study to evaluate whether there is sustained remission and productivity in subjects with early rheumatoid arthritis started on etanercept plus methotrexate treatment.</brief_summary>
	<brief_title>Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>Diagnosis of early rheumatoid arthritis. Methotrexate (MTX) naive. Active early rheumatoid arthritis at the time of enrollment. Previous or current treatment with etanercept, other tumor necrosis factoralpha (TNF) inhibitors, or other biologic agents. Concurrent treatment with any diseasemodifying antirheumatoid drugs (DMARD), within 4 weeks before baseline. Concurrent treatment with more than 1 nonsteroidal antiinflammatory drug (NSAID) at baseline.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>